• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.16% Nasdaq Down0.08%

    United Therapeutics Corporation (UTHR)

    -NasdaqGS
    170.11 Down 2.82(1.63%) Jul 2, 4:00PM EDT
    Add to Portfolio
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):2.3
    Mean Recommendation (last week):2.3
    Change:0.0

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:169.93
    Median Target:170.50
    High Target:225.00
    Low Target:98.00
    No. of Brokers:14

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Mar 12, 2015ArgusUpgradeHoldBuy
    Mar 4, 2015Standpoint ResearchDowngradeBuyHold
    Nov 3, 2014ArgusDowngradeBuyHold
    Oct 15, 2014Standpoint ResearchUpgradeHoldBuy
    Apr 7, 2014Standpoint ResearchUpgradeHoldBuy
    Dec 23, 2013Ladenburg ThalmannUpgradeNeutralBuy
    Jul 30, 2013Standpoint ResearchDowngradeBuyHold
    Jun 20, 2013Standpoint ResearchUpgradeHoldBuy
    May 15, 2013Standpoint ResearchDowngradeBuyHold
    Aug 3, 2012Standpoint ResearchDowngradeBuyHold

    More Upgrades & Downgrades for UTHR

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy4333
    Buy4444
    Hold6778
    Underperform1222
    Sell0000

    Data provided by Thomson/First Call


    Currency in USD.